Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer.

Area of Science:

• Oncology
• Molecular Biology
• Cellular Signaling

Background:

• Cellular lifespan and tumor progression depend on signaling pathways.
• Key pathways facilitate angiogenesis and metastasis via epithelial-mesenchymal transition (EMT).

Purpose of the Study:

• To review critical signaling pathways involved in prostate tumor initiation and progression.
• To discuss the influence of these pathways on cellular processes and EMT in prostate cancer.
• To highlight potential therapeutic targets and novel clinical trials for pathway inhibition.

Main Methods:

• Literature review of signaling pathways including TGF-β, Cripto-1, Wnt, Hedgehog, Notch, and NF-κB.
• Focus on pathways promoting tumor initiation, progression, and EMT in prostate tumors.
• Inclusion of information on therapeutic strategies and clinical trials.

Main Results:

• Identified critical signaling pathways that drive tumor growth, angiogenesis, and metastasis.
• Detailed the mechanisms by which these pathways influence cellular processes and EMT.
• Highlighted the potential of targeting these pathways for prostate cancer therapy.

Conclusions:

• Signaling pathways are crucial drivers of prostate cancer development and metastasis.
• Understanding these pathways offers opportunities for novel therapeutic interventions.
• Ongoing clinical trials show promise for pathway-targeted treatments in prostate cancer.